BNR
$18.38
Burning Rock Biotech Ltd ADR
($.36)
(1.92%)
BNR
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  $0.14
Revenue:  $0.00 Mil
Tuesday
Nov 30
0:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BNR reports earnings?
Beat
Meet
Miss

Where is BNR's stock price going from here?
Up
Flat
Down
Stock chart of BNR
Analysts
Summary of analysts' recommendations for BNR
Score
Grade
Pivots
Resistance
$20.18
$19.63
$19.01

$18.46

Support
$17.83
$17.28
$16.66
Tweet
Growth
Description
Burning Rock Biotech Limited focuses on the application of next generation sequencing technology in the field of precision oncology. Its business consists of NGS-based therapy selection testing for late-stage cancer patients as well as NGS-based cancer early detection. Burning Rock Biotech Limited is based in GUANGZHOU, China.